XINROI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (THE “COMPANY”) ISSUED A NOTICE TO THE REGISTERED SHAREHOLDERS ON 25 APRIL 2024 THAT THE 2023 ANNUAL REPORT, THE ANNUAL GENERAL MEETING CIRCULAR AND RELATED DOCUMENTS ARE AVAILABLE ON THE COMPANY AND THE HKEX LIMITED WEBSITE. The Company encourages shareholders to read these documents via the Website and provides the option for shareholders to request printed copies of the documents. If a printed version is required, shareholders may fill in the return form and return it to Jujia Securities Registration Company Limited by post or email. In addition, the Company also reminds shareholders to update a valid e-mail address in order to receive electronic corporate communications in the future. Shareholders with questions may call the Share Transfer Registration Hotline within working days for enquiries.

XINROI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (THE “COMPANY”) ISSUED A NOTICE TO THE REGISTERED SHAREHOLDERS ON 25 APRIL 2024 THAT THE 2023 ANNUAL REPORT, THE ANNUAL GENERAL MEETING CIRCULAR AND RELATED DOCUMENTS ARE AVAILABLE ON THE COMPANY AND THE HKEX LIMITED WEBSITE. The Company encourages shareholders to read these documents via the Website and provides the option for shareholders to request printed copies of the documents. If a printed version is required, shareholders may fill in the return form and return it to Jujia Securities Registration Company Limited by post or email. In addition, the Company also reminds shareholders to update a valid e-mail address in order to receive electronic corporate communications in the future. Shareholders with questions may call the Share Transfer Registration Hotline within working days for enquiries.